Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
TNFRSF4 expression
i
Other names:
TNF Receptor Superfamily Member 4 , TAX Transcriptionally-Activated Glycoprotein 1 Receptor, Tumor Necrosis Factor Receptor Superfamily Member 4, OX40L Receptor, ACT35 Antigen, CD134 Antigen, TXGP1L, Tax-Transcriptionally Activated Glycoprotein 1 Receptor, Tumor Necrosis Factor Receptor Superfamily, Member 4, Lymphoid Activation Antigene ACT35, OX40 Cell Surface Antigen, OX40 Homologue, ATC35 Antigen, OX40 Antigen, ACT35, CD134, IMD16, OX40
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
22163
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
TNFRSF4 expression
Head and Neck Cancer
TNFRSF4 expression
Head and Neck Cancer
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
TNFRSF4 expression
Gastric Cancer
TNFRSF4 expression
Gastric Cancer
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
TNFRSF4 expression
Acute Myelogenous Leukemia
TNFRSF4 expression
Acute Myelogenous Leukemia
avelumab
Resistant: D – Preclinical
avelumab
Resistant
:
D
avelumab
Resistant: D – Preclinical
avelumab
Resistant
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.